ARTICLE | Clinical News
Indacaterol: Phase II data
May 30, 2005 7:00 AM UTC
Data from a double-blind, placebo-controlled, dose-ranging Phase II trial in 156 patients showed that once-daily QAP149 was safe with no significant effect on ECG measurements, vital signs and lab eva...